Intermittent theta burst stimulation over the posterior superior temporal sulcus for children with autism spectrum disorder: a 4-week randomized blinded controlled trial followed by another 4-week open-label intervention
Recent pharmacovigilance research has identified elevated reporting odds ratios for hair loss with semaglutide (2.46) and tirzepatide (1.73), suggesting a real association between these medications and increased shedding
This dual action makes it a valuable component of a comprehensive weight management and health improvement plan
Some people start with Wegovy, see good results, then switch to Zepbound if they plateau or want to maximize weight loss
The body composition benefit that users expect is inferred, not measured
Retatrutide met the primary endpoints in each trial at 80 weeks, delivering powerful weight loss along with significant improvements in knee osteoarthritis pain and obstructive sleep apnea